NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

JerryCampbell,

Your point of view appears reasonable until you look outside of the box at the big picture. If NWBO had started a new trial they would have been DOOMED!!! No one would have stepped up to rescue NWBO after choosing to increase their monthly burn rate and you obviously know what happened to Mr. Neil Woodford which was their only source of price support. News of a new trial would have sent the share price tumbling and provide Mr. Woodford perfect cover for an even earlier exit. Instead, by October of 2015 Dr. Linda Liau stated that there ought to be a path forward for this trial and she, UCLA and NWBO have been hard at work pioneering that path forward which must be validated by regulators. In the mean time, Fraunhofer seemed pretty pleased with themselves by suggesting that they had "optimized" DCVax-L and then later pretty confident by saying that they only enrolled to the point statistically necessary for the trial while at the same time a German doctor tells the wife of a GBM patient that was randomized to the trial on the SOC/placebo arm but never enrolled that DCVax-L should become available in 2020. This is not the kind of evidence associated with a failed trial. It is the kind of evidence associated with the development of a new norm. Best wishes.